Mucinous ovarian cancer is a distinctive and relatively uncommon type of ovarian cancer — and one of the clearest examples of why a normal CA125 can be misleading. It often makes little CA125, and the markers that matter most for it are usually ones associated with the digestive system.

What it is and how common it is

Mucinous tumors are named for the thick, gel-like mucin their cells produce — the same kind of substance made by the lining of the intestine. True (primary) mucinous ovarian cancer accounts for only a small fraction of ovarian cancers. In fact, one of the most important facts about it is that many ovarian tumors that look mucinous have actually spread to the ovary from somewhere else — most often the appendix, colon, stomach, or pancreas. Confirming that a mucinous cancer truly started in the ovary is a key part of diagnosis.

Primary mucinous ovarian cancer tends to affect younger women than average, often forms a single large mass on one ovary, and is frequently caught at an early stage when it is still confined to the ovary — which is generally good news for prognosis.

How it behaves on a CA125 test

CA125 is frequently normal in mucinous ovarian cancer. Because mucinous cells resemble intestinal tissue rather than the fallopian-tube-like cells that shed CA125, this subtype often signals through different markers. CEA (carcinoembryonic antigen) and CA19-9 — both more commonly linked to gastrointestinal cancers — are often more useful, and are sometimes raised when CA125 is not.

This is why relying on CA125 alone can be a mistake with a mucinous mass. When a mucinous tumor is suspected, doctors typically consider a panel of markers and, given the chance it spread from the gut, may also evaluate the appendix and bowel.

Symptoms and how it’s diagnosed

Mucinous tumors can grow quite large, so symptoms are often related to the physical size of the mass:

Abdominal swelling or a feeling of pressure or fullness
Pelvic pain or discomfort
A palpable mass or increase in abdominal size
Digestive changes as a large mass presses on nearby organs

Because CA125 may be normal, diagnosis leans on imaging — transvaginal ultrasound, CT, or MRI — which can reveal a large, often multi-chambered mass. Blood tests may include CEA and CA19-9 in addition to CA125. When there is any suspicion the cancer came from the digestive tract, evaluation of the appendix and colon (sometimes including colonoscopy) may be recommended. As always, the definitive diagnosis comes from a pathologist examining tissue, usually after surgery.

Treatment and outlook

Surgery is the cornerstone of treatment, both to remove the tumor and to determine whether it is truly a primary ovarian cancer. If the cancer may have come from the appendix, the appendix is sometimes removed as well.

Mucinous ovarian cancer tends to respond less predictably to the platinum-based chemotherapy used for high-grade serous disease. For that reason, when chemotherapy is recommended — usually for more advanced disease — doctors sometimes consider regimens more like those used for gastrointestinal cancers. Treatment is increasingly tailored to the individual tumor’s features.

The outlook is often favorable when the cancer is found early and confined to one ovary, which is common for this subtype. Advanced mucinous cancer is more challenging because of its lower response to standard chemotherapy, which makes complete surgical removal especially important. Prognosis always depends on stage and on how completely the cancer can be removed.

Questions to ask your care team

Has it been confirmed that this cancer started in the ovary rather than spreading from elsewhere?
Should my appendix or colon be evaluated?
Were CEA and CA19-9 checked in addition to CA125?
What chemotherapy approach, if any, is best for a mucinous cancer specifically?
Would molecular testing help guide my treatment?

Why this matters to us

Mucinous cancer is a reminder that “ovarian cancer” is really many diseases, and that the standard tools do not fit all of them. The Cure Ovarian Cancer Foundation supports research and families across every subtype — including the rarer ones that are easy to overlook. If this guide was helpful, please consider donating to help us support the next person searching for answers.

This page is for education and awareness and is not medical advice. Please discuss your diagnosis, testing, and treatment with your own care team.